{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T11:40:02Z","timestamp":1736077202410,"version":"3.32.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04997-z","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:18:13Z","timestamp":1736029093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombin III deficiency and idiopathic intracranial hypertension: a case\u00a0report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-6835","authenticated-orcid":false,"given":"Mansoureh","family":"Togha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3849-7254","authenticated-orcid":false,"given":"Yousef","family":"Mokary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"1","key":"4997_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","volume":"15","author":"KA Markey","year":"2016","unstructured":"Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78\u201391.","journal-title":"Lancet Neurol"},{"issue":"10","key":"4997_CR2","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/01.WNL.0000029570.69134.1B","volume":"59","author":"DI Friedman","year":"2002","unstructured":"Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492\u20135.","journal-title":"Neurology"},{"issue":"11","key":"4997_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.revmed.2022.08.012","volume":"43","author":"F Robelin","year":"2022","unstructured":"Robelin F, Lenfant M, Ricolfi F, B\u00e9jot Y, Comby PO. Idiopathic intracranial hypertension: from physiopathological mechanisms to therapeutic decision. Rev Med Interne. 2022;43(11):661\u20138.","journal-title":"Rev Med Interne"},{"issue":"1","key":"4997_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13256-019-2060-5","volume":"13","author":"A Samara","year":"2019","unstructured":"Samara A, Ghazaleh D, Berry B, Ghannam M. Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report. J Med Case Rep. 2019;13(1):94.","journal-title":"J Med Case Rep"},{"issue":"5","key":"4997_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2011-302029","volume":"83","author":"V Biousse","year":"2012","unstructured":"Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83(5):488\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4997_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332222","author":"BD Colman","year":"2023","unstructured":"Colman BD, Boonstra F, Nguyen MN, Raviskanthan S, Sumithran P, White O, et\u00a0al. Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. J Neurol Neurosurg Psychiatry. 2023.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4997_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/01616412.2019.1710408","volume":"42","author":"H Onder","year":"2020","unstructured":"Onder H, Kisbet T. Neuroimaging findings in patients with idiopathic intracranial hypertension and cerebral venous thrombosis, and their association with clinical features. Neurol Res. 2020;42(2):141\u20137.","journal-title":"Neurol Res"},{"issue":"4","key":"4997_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.7861\/clinmed.2020-0232","volume":"20","author":"BR Wakerley","year":"2020","unstructured":"Wakerley BR, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: update on diagnosis and management. Clin Med. 2020;20(4):384\u20138.","journal-title":"Clin Med"},{"issue":"5","key":"4997_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/NRL.0000000000000242","volume":"24","author":"S T\u00fcray","year":"2019","unstructured":"T\u00fcray S, Kabaku\u015f N, Hanci F, Tun\u00e7lar A, Hizal M. Cause or consequence: the relationship between cerebral venous thrombosis and idiopathic intracranial hypertension. Neurologist. 2019;24(5):155\u201360.","journal-title":"Neurologist"},{"issue":"1","key":"4997_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-2143(03)00069-6","volume":"142","author":"CJ Glueck","year":"2003","unstructured":"Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med. 2003;142(1):35\u201345.","journal-title":"J Lab Clin Med"},{"issue":"3","key":"4997_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/jnnp.62.3.229","volume":"62","author":"J Sussman","year":"1997","unstructured":"Sussman J, Leach M, Greaves M, Malia R, Davies-Jones GA. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1997;62(3):229\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"4997_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1526-4610.2001.041006595.x","volume":"41","author":"DE Jacome","year":"2001","unstructured":"Jacome DE. Idiopathic intracranial hypertension and hemophilia A. Headache. 2001;41(6):595\u20138.","journal-title":"Headache"},{"key":"4997_CR13","doi-asserted-by":"crossref","unstructured":"Haouimi A. Empty sella. Case study, Radiopaedia.org 2023. https:\/\/radiopaedia.org\/cases\/empty-sella-21.","DOI":"10.53347\/rID-175906"},{"key":"4997_CR14","unstructured":"Shetty A, Deng F, Filho R, al. e. Optic nerve sheath diameter. Radiopaedia.org 2024. https:\/\/radiopaedia.org\/articles\/optic-nerve-sheath-diameter?lang=us."},{"issue":"3","key":"4997_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/S031716710002182X","volume":"24","author":"K Gordon","year":"1997","unstructured":"Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci. 1997;24(3):219\u201321.","journal-title":"Can J Neurol Sci"},{"issue":"13","key":"4997_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159\u201365.","journal-title":"Neurology"},{"issue":"10","key":"4997_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et\u00a0al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088\u2013100.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"4997_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/03331024211056580","volume":"42","author":"K Kilic","year":"2022","unstructured":"Kilic K, Korsb\u00e6k JJ, Jensen RH, Cvetkovic VV. Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: a systematic review. Cephalalgia. 2022;42(6):524\u201341.","journal-title":"Cephalalgia"},{"issue":"8","key":"4997_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0000000000004247","volume":"89","author":"M Sodhi","year":"2017","unstructured":"Sodhi M, Sheldon CA, Carleton B, Etminan M. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: nested case-control study. Neurology. 2017;89(8):792\u20135.","journal-title":"Neurology"},{"key":"4997_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3109\/01658107.2010.499524","volume":"34","author":"M Cellini","year":"2010","unstructured":"Cellini M, Strobbe E, Gizzi C, Campos E. Pseudotumour cerebri syndrome and levofloxacin therapy: a case report. Neuro-Ophthalmology. 2010;34:358\u201360.","journal-title":"Neuro-Ophthalmology"},{"issue":"5554","key":"4997_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/bmj.2.5554.744","volume":"2","author":"LO Bor\u00e9us","year":"1967","unstructured":"Bor\u00e9us LO, Sundstr\u00f6m B. Intracranial hypertension in a child during treatment with nalidixic acid. Br Med J. 1967;2(5554):744\u20135.","journal-title":"Br Med J"},{"issue":"3","key":"4997_CR22","first-page":"165","volume":"55","author":"AG Lee","year":"1995","unstructured":"Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis. 1995;55(3):165\u20138.","journal-title":"Cutis"},{"issue":"2","key":"4997_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jaapos.2008.11.001","volume":"13","author":"SJ Kelly","year":"2009","unstructured":"Kelly SJ, O\u2019Donnell T, Fleming JC, Einhaus S. Pseudotumor cerebri associated with lithium use in an 11-year-old boy. J aapos. 2009;13(2):204\u20136.","journal-title":"J aapos"},{"issue":"4","key":"4997_CR24","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1176\/appi.neuropsych.11100237","volume":"24","author":"S Sur","year":"2012","unstructured":"Sur S, Chauhan A. Methotrexate-induced pseudotumor cerebri and psychosis in a case of rheumatoid arthritis. J Neuropsychiatry Clin Neurosci. 2012;24(4):E18.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"4997_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3389\/fphar.2020.00839","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Qiu Y, Wang Z, Wang R, Jin R, Hinkle LE, Wu X. High-dose methotrexate-induced idiopathic intracranial hypertension in infant acute lymphoblastic leukemia. Front Pharmacol. 2020;11:839.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4997_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0002-9394(14)72077-X","volume":"122","author":"OA Cruz","year":"1996","unstructured":"Cruz OA, Fogg SG, Roper-Hall G. Pseudotumor cerebri associated with cyclosporine use. Am J Ophthalmol. 1996;122(3):436\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"4997_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232725","volume":"12","author":"CW Yu","year":"2019","unstructured":"Yu CW, Kwok JM, Micieli JA. Resolution of papilledema associated with cyclosporine use after change to tacrolimus. BMJ Case Rep. 2019;12(11): e232725.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"4997_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/practneurol-2014-000934","volume":"15","author":"JD Benzimra","year":"2015","unstructured":"Benzimra JD, Simon S, Sinclair AJ, Mollan SP. Sight-threatening pseudotumour cerebri associated with excess vitamin A supplementation. Pract Neurol. 2015;15(1):72\u20133.","journal-title":"Pract Neurol"},{"issue":"3","key":"4997_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/01658107.2017.1367931","volume":"42","author":"JT Chisholm","year":"2018","unstructured":"Chisholm JT, Abou-Jaoude MM, Hessler AB, Sudhakar P. Pseudotumor cerebri syndrome with resolution after discontinuing high vitamin A containing dietary supplement: case report and review. Neuroophthalmology. 2018;42(3):169\u201375.","journal-title":"Neuroophthalmology"},{"issue":"4","key":"4997_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/WNO.0000000000000374","volume":"36","author":"YM Mohammad","year":"2016","unstructured":"Mohammad YM, Raslan IR, Al-Hussain FA. Idiopathic intracranial hypertension induced by topical application of vitamin A. J Neuroophthalmol. 2016;36(4):412\u20133.","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"4997_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4103\/0976-3147.139991","volume":"5","author":"AM Ramana Reddy","year":"2014","unstructured":"Ramana Reddy AM, Prashanth LK, Sharat Kumar GG, Chandana G, Jadav R. Over-the-counter self-medication leading to intracranial hypertension in a young lady. J Neurosci Rural Pract. 2014;5(4):384\u20136.","journal-title":"J Neurosci Rural Pract"},{"issue":"6","key":"4997_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/088307380101600617","volume":"16","author":"A Levine","year":"2001","unstructured":"Levine A, Watemberg N, Hager H, Bujanover Y, Ballin A, Lerman-Sagie T. Benign intracranial hypertension associated with budesonide treatment in children with Crohn\u2019s disease. J Child Neurol. 2001;16(6):458\u201361.","journal-title":"J Child Neurol"},{"issue":"5","key":"4997_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jcjo.2014.06.012","volume":"49","author":"A Espino Barros Palau","year":"2014","unstructured":"Espino Barros Palau A, Morgan ML, Foroozan R, Lee AG. Neuro-ophthalmic presentations and treatment of cryptococcal meningitis-related increased intracranial pressure. Can J Ophthalmol. 2014;49(5):473\u20137.","journal-title":"Can J Ophthalmol"},{"key":"4997_CR34","first-page":"2854043","volume":"2017","author":"JC Beal","year":"2017","unstructured":"Beal JC. Increased intracranial pressure in the setting of Enterovirus and other viral meningitides. Neurol Res Int. 2017;2017:2854043.","journal-title":"Neurol Res Int"},{"issue":"6","key":"4997_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5001\/omj.2017.96","volume":"32","author":"PP Sharma","year":"2017","unstructured":"Sharma PP, Murali MV, Hamdi T. Neurobrucellosis presenting as pseudotumor cerebri: first report from Oman. Oman Med J. 2017;32(6):507\u20139.","journal-title":"Oman Med J"},{"key":"4997_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222976","author":"M Ezequiel","year":"2018","unstructured":"Ezequiel M, Teixeira AT, Brito MJ, Lu\u00eds C. Pseudotumor cerebri as the presentation of Lyme disease in a non-endemic area. BMJ Case Rep. 2018.","journal-title":"BMJ Case Rep"},{"key":"4997_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.09.2011.4813","volume":"2011","author":"H Yri","year":"2011","unstructured":"Yri H, Wegener M, Jensen R. Syphilis mimicking idiopathic intracranial hypertension. BMJ Case Rep. 2011;2011: bcr0920114813.","journal-title":"BMJ Case Rep"},{"issue":"8","key":"4997_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2169\/internalmedicine.55.5990","volume":"55","author":"E Katsuyama","year":"2016","unstructured":"Katsuyama E, Sada KE, Tatebe N, Watanabe H, Katsuyama T, Narazaki M, et\u00a0al. Bilateral abducens nerve palsy due to idiopathic intracranial hypertension as an initial manifestation of systemic lupus erythematosus. Intern Med. 2016;55(8):991\u20134.","journal-title":"Intern Med"},{"issue":"2","key":"4997_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0961203312464804","volume":"22","author":"C Tse","year":"2013","unstructured":"Tse C, Klein R. Intracranial hypertension associated with systemic lupus erythematosus in a young male patient. Lupus. 2013;22(2):205\u201312.","journal-title":"Lupus"},{"issue":"7","key":"4997_CR40","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/rheumatology\/ker449","volume":"51","author":"N Noel","year":"2012","unstructured":"Noel N, Huti\u00e9 M, Wechsler B, Vignes S, Le Thi H-B, Amoura Z, et\u00a0al. Pseudotumoural presentation of neuro-Behcet\u2019s disease: case series and review of literature. Rheumatology. 2012;51(7):1216\u201325.","journal-title":"Rheumatology"},{"issue":"12","key":"4997_CR41","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0161-6420(98)91234-9","volume":"105","author":"LN Johnson","year":"1998","unstructured":"Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313\u20137.","journal-title":"Ophthalmology"},{"issue":"2","key":"4997_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/088307389400900205","volume":"9","author":"JF Schoeman","year":"1994","unstructured":"Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9(2):130\u20134.","journal-title":"J Child Neurol"},{"issue":"16","key":"4997_CR43","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2014.3312","volume":"311","author":"M Wall","year":"2014","unstructured":"Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et\u00a0al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641\u201351.","journal-title":"JAMA"},{"issue":"4","key":"4997_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/107602960501100411","volume":"11","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, Goldenberg N, Golnik K, Sieve L, Wang P. Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men. Clin Appl Thromb Hemost. 2005;11(4):441\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"4997_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-012-0207-4","volume":"15","author":"MJ Thurtell","year":"2013","unstructured":"Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013;15(1):1\u201312.","journal-title":"Curr Treat Options Neurol"},{"key":"4997_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fneur.2015.00013","volume":"6","author":"JG Millichap","year":"2015","unstructured":"Millichap JG, Millichap JJ. Mechanism of action of acetazolamide and idiopathic intracranial hypertension. Front Neurol. 2015;6:13.","journal-title":"Front Neurol"},{"key":"4997_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2018.07.008","volume":"169","author":"J Corral","year":"2018","unstructured":"Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018;169:23\u20139.","journal-title":"Thromb Res"},{"issue":"4","key":"4997_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1447-0756.2001.tb01250.x","volume":"27","author":"T Yamada","year":"2001","unstructured":"Yamada T, Yamada H, Morikawa M, Kato EH, Kishida T, Ohnaka Y, et\u00a0al. Management of pregnancy with congenital antithrombin III deficiency: two case reports and a review of the literature. J Obstet Gynaecol Res. 2001;27(4):189\u201397.","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"4997_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1042\/CS20160669","volume":"131","author":"Z Lu","year":"2017","unstructured":"Lu Z, Wang F, Liang M. SerpinC1\/Antithrombin III in kidney-related diseases. Clin Sci. 2017;131(9):823\u201331.","journal-title":"Clin Sci"},{"issue":"1","key":"4997_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s41983-019-0106-7","volume":"55","author":"H Shaheen","year":"2019","unstructured":"Shaheen H, Sobhy S, El Mously S, El Khatib M, Hamdy A. Quantitative d-dimer level and anticoagulant therapy in idiopathic intracranial hypertension. Egypt J Neurol Psychiatry Neurosurg. 2019;55(1):62.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"issue":"3","key":"4997_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10815-013-0171-2","volume":"31","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sun MG, Jiang R, Ding R, Che Z, Chen YY, et\u00a0al. Plasminogen activator inhibitor-1 -675 4G\/5G polymorphism and polycystic ovary syndrome risk: a meta analysis. J Assist Reprod Genet. 2014;31(3):363\u201370.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"4997_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lab.2004.09.011","volume":"145","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med. 2005;145(2):72\u201382.","journal-title":"J Lab Clin Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04997-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04997-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04997-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T11:02:10Z","timestamp":1736074930000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04997-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4997"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04997-z","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Tehran University of Medical Sciences. The details of this study were explained to the patient, and the patient provided informed consent to participate in the project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this study and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}